Published in Front Microbiol on June 21, 2012
Pathways of cell-cell transmission of HTLV-1. Front Microbiol (2012) 1.02
Molecular Mechanisms of HTLV-1 Cell-to-Cell Transmission. Viruses (2016) 0.84
IL28B gene polymorphism SNP rs8099917 genotype GG is associated with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-1 carriers. PLoS Negl Trop Dis (2014) 0.78
HTLV-1, Immune Response and Autoimmunity. Viruses (2015) 0.77
Modes of Human T Cell Leukemia Virus Type 1 Transmission, Replication and Persistence. Viruses (2015) 0.77
Receptor usage and the pathogenesis in acute and chronic virus infections. Front Microbiol (2012) 0.75
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A (1980) 30.08
Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci U S A (1983) 14.09
Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet (1985) 13.47
Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A (1982) 12.84
Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A (1981) 11.92
HTLV-I associated myelopathy, a new clinical entity. Lancet (1986) 10.49
Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell (1998) 10.32
Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science (1984) 9.14
A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell (1999) 6.82
The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. Science (1985) 6.60
Virus entry: open sesame. Cell (2006) 6.33
Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science (2003) 5.19
Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein. Cell (2000) 4.88
Global epidemiology of HTLV-I infection and associated diseases. Oncogene (2005) 4.77
Functional activation of the long terminal repeat of human T-cell leukemia virus type I by a trans-acting factor. Proc Natl Acad Sci U S A (1985) 4.24
The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J Virol (2002) 3.01
High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans. Science (1989) 3.00
The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma. Int J Cancer (1982) 2.71
In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol (1990) 2.70
Identification of the gene responsible for human T-cell leukaemia virus transcriptional regulation. Nature (1986) 2.49
A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response. Nat Immunol (2002) 2.47
Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins. Proc Natl Acad Sci U S A (1999) 2.32
The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell (2003) 2.28
Productive infection and cell-free transmission of human T-cell leukemia virus in a nonlymphoid cell line. Science (1983) 2.26
The strength of T cell receptor signal controls the polarization of cytotoxic machinery to the immunological synapse. Immunity (2009) 2.16
Discovery of adult T-cell leukemia. Retrovirology (2005) 2.13
Human T-cell leukemia virus type I: induction of syncytia and inhibition by patients' sera. Int J Cancer (1983) 2.08
Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells. Nat Med (2008) 2.07
Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol (1997) 1.99
Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1. Blood (2006) 1.98
Isomerization of the intersubunit disulphide-bond in Env controls retrovirus fusion. EMBO J (2003) 1.93
Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses. Nat Med (2009) 1.92
Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol (1995) 1.91
Human immunodeficiency virus type 1 virological synapse formation in T cells requires lipid raft integrity. J Virol (2005) 1.90
A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes. J Virol (1998) 1.89
Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2. Oncogene (2005) 1.73
Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors. J Virol (2001) 1.73
Infection of human endothelial cells by human T-lymphotropic virus type I. Proc Natl Acad Sci U S A (1984) 1.73
Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy. Oncogene (2010) 1.67
Infection of human endothelial cells by human T-cell leukemia virus type I. Proc Natl Acad Sci U S A (1984) 1.61
Chronic neurodegenerative disease associated with HTLV-II infection. Lancet (1992) 1.58
Sexual transmission of human T-lymphotropic virus type I (HTLV-I). Ann Intern Med (1989) 1.57
Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med (1992) 1.56
Broad host range of human T-cell leukemia virus type 1 demonstrated with an improved pseudotyping system. J Virol (1996) 1.53
Identification of gag and env gene products of human T-cell leukemia virus (HTLV). Virology (1984) 1.53
Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells. J Virol (2005) 1.53
Human T-lymphotropic virus, type 1, tax protein triggers microtubule reorientation in the virological synapse. J Biol Chem (2005) 1.45
Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling. EMBO J (2006) 1.45
Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation. AIDS Res Hum Retroviruses (1992) 1.45
Human T-cell leukemia virus type I envelope protein maturation process: requirements for syncytium formation. J Virol (1992) 1.44
In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology (1993) 1.43
Detection of lymphocytes producing a human retrovirus associated with adult T-cell leukemia by syncytia induction assay. Proc Natl Acad Sci U S A (1983) 1.43
Infection of peripheral blood mononuclear cells and cell lines by cell-free human T-cell lymphoma/leukemia virus type I. J Clin Microbiol (1992) 1.42
Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization. J Immunol (1991) 1.39
Intrafamilial transmission of adult T cell leukemia virus. J Infect Dis (1986) 1.38
Human T-cell leukemia/lymphoma virus type 1 nonstructural genes and their functions. Oncogene (2005) 1.38
Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion. J Virol (2004) 1.37
Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectors. PLoS Pathog (2010) 1.36
In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection. Proc Natl Acad Sci U S A (2007) 1.36
Human T-cell leukemia virus (HTLV-I) antibodies in Africa. Science (1984) 1.35
Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity (2000) 1.34
Human T-lymphotropic virus type 1 open reading frame I p12(I) is required for efficient viral infectivity in primary lymphocytes. J Virol (2000) 1.34
Human T-lymphotropic virus type II and neurological disease. Ann Neurol (2004) 1.32
Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). J Emerg Med (2000) 1.32
Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins. J Virol (1992) 1.32
CD8(+) T cells are an in vivo reservoir for human T-cell lymphotropic virus type I. Blood (2001) 1.27
HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165. Blood (2009) 1.27
Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry. J Virol (2006) 1.26
Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans. J Virol (2003) 1.26
Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells. Int Immunol (2005) 1.21
High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. Blood (2002) 1.20
Identification of functional regions in the human T-cell leukemia virus type I SU glycoprotein. J Virol (1994) 1.19
Human T-lymphotropic virus-1 visualized at the virological synapse by electron tomography. PLoS One (2008) 1.16
Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation. Oncogene (2005) 1.15
Regulatory T-cell function of adult T-cell leukemia/lymphoma cells. Int J Cancer (2007) 1.14
Cell-surface heparan sulfate facilitates human immunodeficiency virus Type 1 entry into some cell lines but not primary lymphocytes. Virus Res (1999) 1.14
The HTLV receptor is a widely expressed protein. Virology (2000) 1.13
HTLV-1-Tax and ICAM-1 act on T-cell signal pathways to polarize the microtubule-organizing center at the virological synapse. Blood (2009) 1.12
Definition of an amino-terminal domain of the human T-cell leukemia virus type 1 envelope surface unit that extends the fusogenic range of an ecotropic murine leukemia virus. J Biol Chem (2000) 1.12
HTLV-1 and -2 envelope SU subdomains and critical determinants in receptor binding. Retrovirology (2004) 1.12
Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells. J Virol (2006) 1.09
Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission. Proc Natl Acad Sci U S A (2010) 1.09
Functional implications of the human T-lymphotropic virus type 1 transmembrane glycoprotein helical hairpin structure. J Virol (2000) 1.08
T-cell activation by autologous human T-cell leukemia virus type I-infected T-cell clones. Proc Natl Acad Sci U S A (1992) 1.08
In vivo cellular tropism of human T cell leukemia virus type II (HTLV-II). J Exp Med (1992) 1.08
Ethnoepidemiology of HTLV-1 related diseases: ethnic determinants of HTLV-1 susceptibility and its worldwide dispersal. Cancer Sci (2011) 1.08
Detection of human T cell lymphotropic virus type I proviral DNA and its gene expression in synovial cells in chronic inflammatory arthropathy. J Clin Invest (1991) 1.07
Experimental infection of rabbits with human T-cell leukemia virus type I. Jpn J Cancer Res (1985) 1.05
HTLV-1 tropism and envelope receptor. Oncogene (2005) 1.05
Foxp3 expression on normal and leukemic CD4+CD25+ T cells implicated in human T-cell leukemia virus type-1 is inconsistent with Treg cells. Eur J Haematol (2008) 1.05
FoxP3+ regulatory T cells are distinct from leukemia cells in HTLV-1-associated adult T-cell leukemia. Int J Cancer (2009) 1.05
Protection of cynomolgus monkeys against infection by human T-cell leukemia virus type-I by immunization with viral env gene products produced in Escherichia coli. Int J Cancer (1987) 1.04
Mother-to-child transmission of human T-cell-leukemia/lymphoma virus type I: implication of high antiviral antibody titer and high proviral load in carrier mothers. Int J Cancer (1999) 1.04
Low pH is required for avian sarcoma and leukosis virus Env-dependent viral penetration into the cytosol and not for viral uncoating. J Virol (2004) 1.03
HTLV-1 Gag protein associates with CD82 tetraspanin microdomains at the plasma membrane. Virology (2005) 1.03
The human HTLV-3 and HTLV-4 retroviruses: new members of the HTLV family. Pathol Biol (Paris) (2008) 1.02
The HTLV receptor is an early T-cell activation marker whose expression requires de novo protein synthesis. Blood (2002) 1.02
Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine. J Immunol (1993) 1.02